CN111323519A - Method for detecting triethylamine in propane fumarate tenofovir disoproxil through gas chromatography - Google Patents

Method for detecting triethylamine in propane fumarate tenofovir disoproxil through gas chromatography Download PDF

Info

Publication number
CN111323519A
CN111323519A CN202010286832.XA CN202010286832A CN111323519A CN 111323519 A CN111323519 A CN 111323519A CN 202010286832 A CN202010286832 A CN 202010286832A CN 111323519 A CN111323519 A CN 111323519A
Authority
CN
China
Prior art keywords
triethylamine
solution
fumarate
gas chromatography
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010286832.XA
Other languages
Chinese (zh)
Inventor
张春燕
吉丽峰
姜春阳
谢军
李惠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Haiyuekang Pharmaceutical Technology Co ltd
Original Assignee
Jiangsu Haiyuekang Pharmaceutical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Haiyuekang Pharmaceutical Technology Co ltd filed Critical Jiangsu Haiyuekang Pharmaceutical Technology Co ltd
Priority to CN202010286832.XA priority Critical patent/CN111323519A/en
Publication of CN111323519A publication Critical patent/CN111323519A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • G01N30/14Preparation by elimination of some components
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/16Injection
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/30Control of physical parameters of the fluid carrier of temperature
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/32Control of physical parameters of the fluid carrier of pressure or speed
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/64Electrical detectors
    • G01N30/68Flame ionisation detectors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/86Signal analysis
    • G01N30/8624Detection of slopes or peaks; baseline correction
    • G01N30/8631Peaks
    • G01N30/8634Peak quality criteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N2030/042Standards
    • G01N2030/047Standards external
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • G01N2030/067Preparation by reaction, e.g. derivatising the sample
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/30Control of physical parameters of the fluid carrier of temperature
    • G01N2030/3046Control of physical parameters of the fluid carrier of temperature temperature control of column inlet
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/32Control of physical parameters of the fluid carrier of pressure or speed
    • G01N2030/324Control of physical parameters of the fluid carrier of pressure or speed speed, flow rate
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/884Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Quality & Reliability (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The invention discloses a method for detecting triethylamine in tenofovir disoproxil fumarate by gas chromatography, which comprises the steps of respectively detecting a sample solution of the tenofovir disoproxil fumarate and a reference solution by the gas chromatography, recording chromatograms of the sample solution and the reference solution, obtaining peak areas of triethylamine in the sample solution of the tenofovir disoproxil fumarate and the reference solution, and quantitatively analyzing the triethylamine in the sample solution by an external standard method.

Description

Method for detecting triethylamine in propane fumarate tenofovir disoproxil through gas chromatography
Technical Field
The invention relates to the technical field of drug analysis, in particular to a method for detecting triethylamine in propane fumarate tenofovir through gas chromatography.
Background
Propofovir fumarate, chemically known as L-alanine- [ N- [ (S) - [ [ (1R) -2- (6-amino-9H-purin-9-yl) -1-methylethoxy ] methyl ] phenoxyphosphoryloxy ] ] -1-methylethyl ester, (2E) -2-butenedioate (2: 1), having the chemical structure:
Figure BDA0002448850110000011
the valproic acid Propofovir fumarate is a second-generation oral prodrug of tenofovir, and prodrug groups on two hydroxyl groups in phosphoric acid are converted on the basis of the structure of tenofovir, namely, the dipivoxil is converted into an amide and a phenolic ester, so that the valproic acid fumarate is an esterified amidated prodrug. The reconstruction overcomes the defects that tenofovir disoproxil is unstable in blood plasma and is easy to be hydrolyzed by esterase, further improves the delivery rate of tenofovir to liver cells, Peripheral Blood Mononuclear Cells (PBMC) and lymphoid organs, achieves obvious attenuation and synergism effects, and has the effective dose about 25 times lower than TDF.
Triethylamine is a solvent adopted in the synthesis process of the propane fumarate tenofovir, and the fumaric acid in the structure of the propane fumarate tenofovir can interfere with the detection of triethylamine in a sample, so that the research establishes a method for detecting triethylamine in the propane fumarate tenofovir by gas chromatography (headspace sampling), can effectively avoid the interference of the fumaric acid on the detection of the triethylamine, and has the advantages of high sensitivity, strong specificity and high accuracy.
Disclosure of Invention
The invention aims to solve the problems and provides a method for determining triethylamine in the propane fumarate tenofovir, which is simple to operate, accurate in result and high in sensitivity.
The technical scheme of the invention is that the method for detecting triethylamine in the propane fumarate tenofovir comprises the steps of respectively detecting a test solution and a reference solution of the propane fumarate tenofovir by using a gas chromatography, recording chromatograms of the test solution and the reference solution, obtaining peak areas of triethylamine in the test solution and the reference solution of the propane fumarate tenofovir, and carrying out quantitative analysis on the triethylamine in the propane fumarate tenofovir by using an external standard method.
As a further description of the method for determining triethylamine in the fumaric acid, namely, propanphenol tenofovir disoproxil, the present invention uses N, N-dimethylformamide as a solvent for dissolving a sample, and 0.3ml of sodium hydroxide solution (300mg/ml) is added to neutralize fumaric acid in the sample structure in advance.
As a further description of the method for determination of triethylamine in the fumaric acid, propofol, tenofovir, the formulation of a blank solution: 1ml of N, N-dimethylformamide was precisely measured and placed in a 20ml headspace bottle, and 0.3ml of sodium hydroxide solution (300mg/ml) was added thereto and sealed.
As a further description of the method for determining triethylamine in the malonic acid fumarate, tenofovir disoproxil was prepared: taking a proper amount of triethylamine, precisely weighing, adding N, N-dimethylformamide to dissolve and dilute to prepare a solution containing about 500 mu g of triethylamine in each 1ml, precisely weighing 1ml, placing in a 20ml headspace bottle, adding 0.3ml of sodium hydroxide solution (300mg/ml), and sealing.
As a further description of the method for determining triethylamine in the malonic acid fumarate, a test solution was prepared: precisely weighing 0.1g of sample, placing in a 20ml headspace bottle, adding 1ml of N, N-dimethylformamide for dissolving, adding 0.3ml of sodium hydroxide solution (300mg/ml), and sealing.
As a further description of the method for determining triethylamine in the Propofovir fumarate, an Agilent 7890B gas chromatograph is adopted, an Agi lent7697A headspace sample injector is adopted, a chromatographic column is Agi lent CP-Volamines (30 × 0.32mm), the initial column temperature is 45 ℃, the initial column temperature is maintained for 5 minutes, the temperature is raised to 220 ℃ at the rate of 20 ℃ per minute, the injection port temperature is 220 ℃, a detector is a hydrogen flame ionization detector, the detector temperature is 220 ℃, carrier gas is nitrogen, the split ratio is 50: 1, the hydrogen flow is 30ml/min, the oxygen flow is 300ml/min, the nitrogen flow is 25ml/min, the flow rate is 2.0ml/min, the equilibrium temperature of a headspace bottle is 85 ℃, the quantitative ring temperature is 120 ℃, the transmission line temperature is 130 ℃, and the equilibrium time is 30 minutes.
As a further description of the method for determining triethylamine in the propane fumarate tenofovir, the column flow rate may be set to 1.8ml/min to 2.2 ml/min.
As a further description of the method for determining triethylamine in the propane fumarate tenofovir, the injection inlet temperature may be set to 210-230 ℃.
As a further description of the method for determining triethylamine in the propane fumarate tenofovir, the initial column temperature may be set at 40 ℃ to 50 ℃.
Compared with the common residual solvent detection technology, the method has the advantages that a proper amount of sodium hydroxide solution is added to react with fumaric acid in a test sample, so that the interference of the fumaric acid can be eliminated, and the method is more favorable for accurately determining the triethylamine content in the test sample. Through verification, the method is high in sensitivity, strong in specificity and high in accuracy.
Drawings
FIG. 1 is a chromatogram of a control solution from example 1;
FIG. 2 is a chromatogram of a sample solution added with a standard in example 1;
FIG. 3 is a chromatogram of a control solution from example 2;
FIG. 4 is a chromatogram of a sample solution added with a standard in example 2;
FIG. 5 is a chromatogram of a control solution from example 3;
FIG. 6 is a chromatogram of the test sample solution added in example 3;
FIG. 7 is a chromatogram of a control solution from example 4;
FIG. 8 is a chromatogram of the test sample solution added in example 4;
FIG. 9 is a chromatogram of a control solution from example 5;
FIG. 10 is a chromatogram of the test sample solution added with the standard of example 5;
FIG. 11 is a chromatogram of a blank solution from example 5;
FIG. 12 is a chromatogram of the test solution of example 5.
Detailed Description
The examples are provided for better illustration of the present invention, but the present invention is not limited to the examples.
The instrument and chromatographic conditions used in the following examples were Agi lent 7890B gas chromatograph with Agi lent7697A headspace sampler, Agi lent CP-Volamines (30 × 0.32.32 mm) as chromatographic column, initial column temperature of 45 deg.C, 5 minutes hold, and then 20 deg.C per minute rate of temperature up to 220 deg.C, inlet temperature of 220 deg.C, detector temperature of 220 deg.C, carrier gas of nitrogen, split ratio of 50: 1, hydrogen flow of 30ml/min, oxygen flow of 300ml/min, nitrogen flow of 25ml/min, flow rate of 2.0ml/min, headspace bottle equilibrium temperature of 85 deg.C, quantitative loop temperature of 120 deg.C, transmission line temperature of 130 deg.C, and equilibration time of 30 minutes.
EXAMPLE 1 treatment of test articles without sodium hydroxide solution
Solution preparation:
table 1 example 1 solution formulation
Figure BDA0002448850110000041
And (4) respectively taking the solutions to perform headspace sample injection, and recording a chromatogram. The test results are as follows:
table 2 example 1 test results
Name of solution Peak area of triethylamine
Control solution 1066.2
Test solution Not detected out
Adding standard sample solution 153.8
The result shows that the peak area of triethylamine in the solution of the standard sample is obviously lower than that of the reference sample at the same concentration, and the recovery rate is 14.4%, which indicates that the method is not suitable for detecting triethylamine in the propane fumarate tenofovir.
Example 2 sodium hydroxide solution addition: 150mg/ml, 0.2ml
Solution preparation:
table 3 example 2 solution formulation
Figure BDA0002448850110000051
And (4) respectively taking the solutions to perform headspace sample injection, and recording a chromatogram. The test results are as follows:
table 4 example 2 test results
Name of solution Peak area of triethylamine
Control solution 1834.6
Test solution Not detected out
Adding standard sample solution 1424.1
The result shows that the area of the triethylamine peak in the standard sample solution is obviously increased, the sodium hydroxide adding amount is already excessive under the condition, but the recovery rate is only 77.6%.
Example 3 sodium hydroxide solution addition: 300mg/ml, 0.2ml
Solution preparation:
table 5 example 3 solution formulation
Figure BDA0002448850110000061
And (4) respectively taking the solutions to perform headspace sample injection, and recording a chromatogram. The test results are as follows:
table 6 example 3 test results
Name of solution Peak area of triethylamine
Control solution 1979.6
Test solution Not detected out
Adding standard sample solution 1838.1
The result shows that the recovery rate of triethylamine in the standard sample is 92.9%, and the requirement on the recovery rate in the verification guidance principle of the four-part general rule 9101 drug quality standard analysis method in the Chinese pharmacopoeia 2015 edition is met.
Example 4 sodium hydroxide solution addition: 300mg/ml, 0.4ml
Solution preparation:
table 7 example 4 solution formulation
Figure BDA0002448850110000071
And (4) respectively taking the solutions to perform headspace sample injection, and recording a chromatogram. The test results are as follows:
table 8 example 4 test results
Name of solution Peak area of triethylamine
Control solution 1911.3
Test solution Not detected out
Adding standard sample solution 2016.4
The result shows that the recovery rate of triethylamine in the added standard test sample is 105.5 percent, the requirement on the recovery rate in the verification and guidance principle of the four-part rule 9101 drug quality standard analysis method in the Chinese pharmacopoeia 2015 edition is met, but more sodium hydroxide is precipitated in the test sample solution.
Example 5 sodium hydroxide solution addition: 300mg/ml, 0.3ml
Solution preparation:
table 9 example 5 solution formulation
Figure BDA0002448850110000081
And (4) respectively taking the solutions to perform headspace sample injection, and recording a chromatogram. The test results are as follows:
table 10 example 5 test results
Name of solution Peak area of triethylamine
Control solution 1922.6
Test solution Not detected out
Adding standard sample solution 1851.9
The result shows that the recovery rate of triethylamine in the standard sample is 96.3%, the requirement on the recovery rate in the verification guidance principle of the quality standard analysis method of 9101 drugs in the four-part general rule of the national pharmacopoeia 2015 edition is met, and sodium hydroxide is not precipitated, so that the methodological verification is carried out by the method.
Methodology validation results:
TABLE 11 Linear verification results
Figure BDA0002448850110000091
TABLE 12 accuracy verification results
Figure BDA0002448850110000092
The verification result shows that the detection method has strong specificity, high sensitivity and high accuracy.
The technical solutions described above only represent the preferred technical solutions of the present invention, and some possible modifications to some parts of the technical solutions by those skilled in the art all represent the principles of the present invention, and fall within the protection scope of the present invention.

Claims (9)

1. The method for detecting triethylamine in the fumaric acid Propofol tenofovir through gas chromatography is characterized by comprising the following steps: respectively detecting the propane fumarate tenofovir disoproxil fumarate test solution and the reference solution by adopting a gas chromatography, recording chromatograms of the test solution and the reference solution, obtaining peak areas of triethylamine in the propane fumarate tenofovir disoproxil test solution and the reference solution, and quantitatively analyzing the triethylamine in the test solution by using an external standard method; the reference solution is a pure triethylamine solution.
2. The method for detecting triethylamine in the preparation of propiofuravir fumarate by gas chromatography as claimed in claim 1, wherein N, N-dimethylformamide is used as a solvent for dissolving the sample, and 0.3ml of sodium hydroxide solution (300mg/ml) is added to neutralize the fumaric acid in the structure of propiofuravir fumarate in advance.
3. The method for detecting triethylamine in the propanefenovir fumarate according to claim 1, characterized in that an Agilent 7890B gas chromatograph is used with an Agilent7697A headspace sample injector.
4. The method for detecting triethylamine in the propanefenovir fumarate according to claim 1, wherein the chromatographic column is Agilent CP-Volamines (30 × 0.32.32 mm), and the flow rate of the column can be set to 1.8 ml/min-2.2 ml/min.
5. The gas chromatography detection method for triethylamine in tenofovir disoproxil fumarate according to claim 1, wherein the initial column temperature can be set to 40-50 ℃, maintained for 5 minutes, and then increased to 220 ℃ at a rate of 20 ℃ per minute.
6. The gas chromatography detection method for triethylamine in the propanefenovir fumarate as claimed in claim 1, wherein the injection port temperature can be set to 210-230 ℃.
7. The gas chromatography detection method for triethylamine in the propanefenovir fumarate as claimed in claim 1, wherein the detector is a hydrogen flame ionization detector, and the temperature of the detector is 220 ℃.
8. The gas chromatography detection method for triethylamine in the fumaric acid Propofovir through the method according to claim 1, wherein the carrier gas is nitrogen, and the split ratio is 50: 1, hydrogen flow 30ml/min, oxygen flow 300ml/min, nitrogen flow 25 ml/min.
9. The gas chromatography detection method for triethylamine in propylphenol fumarate tenofovir according to claim 1, wherein the equilibrium temperature of the headspace bottle is 85 ℃, the quantitative loop temperature is 120 ℃, the transfer line temperature is 130 ℃, and the equilibrium time is 30 minutes.
CN202010286832.XA 2020-04-13 2020-04-13 Method for detecting triethylamine in propane fumarate tenofovir disoproxil through gas chromatography Pending CN111323519A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010286832.XA CN111323519A (en) 2020-04-13 2020-04-13 Method for detecting triethylamine in propane fumarate tenofovir disoproxil through gas chromatography

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010286832.XA CN111323519A (en) 2020-04-13 2020-04-13 Method for detecting triethylamine in propane fumarate tenofovir disoproxil through gas chromatography

Publications (1)

Publication Number Publication Date
CN111323519A true CN111323519A (en) 2020-06-23

Family

ID=71169890

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010286832.XA Pending CN111323519A (en) 2020-04-13 2020-04-13 Method for detecting triethylamine in propane fumarate tenofovir disoproxil through gas chromatography

Country Status (1)

Country Link
CN (1) CN111323519A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111735884A (en) * 2020-08-04 2020-10-02 精晶药业股份有限公司 High performance gas chromatography detection method for triethylamine content in feed liquid
CN112379019A (en) * 2020-11-06 2021-02-19 郑州原理生物科技有限公司 Method for detecting residual solvent diethylamine in lidocaine hydrochloride
CN112782311A (en) * 2020-12-30 2021-05-11 南京百泽医药科技有限公司 HPLC (high performance liquid chromatography) determination method of L-isopropyl alanine in tenofovir disoproxil fumarate
CN112903866A (en) * 2021-02-02 2021-06-04 郑州泰丰制药有限公司 Method for determining triethylamine content in propane fumarate tenofovir
WO2022151842A1 (en) * 2021-01-14 2022-07-21 浙江海正药业股份有限公司 Gas-phase chromatography detection method for dicyclohexylamine in favipiravir

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006030534A (en) * 2004-07-15 2006-02-02 Ricoh Co Ltd Method for measuring molecular weight distribution of toner
CN101324551A (en) * 2007-06-12 2008-12-17 广东康虹医药有限公司 Quality control method of rupatadine fumarate

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006030534A (en) * 2004-07-15 2006-02-02 Ricoh Co Ltd Method for measuring molecular weight distribution of toner
CN101324551A (en) * 2007-06-12 2008-12-17 广东康虹医药有限公司 Quality control method of rupatadine fumarate

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DIAN SISWANTO 等: "Uptake and degradation of trimethylamine by Euphorbia milii", 《ENVIRON SCI POLLUT RES》 *
T.NEVIGATO 等: "TRIMETHYLAMINE AS A FRESHNESS INDICATOR FOR SEAFOOD STORED IN ICE:ANALYSIS BY GC-FID OF FOUR SPECIES CAUGHT IN THE TYRRHENIAN SEA", 《ITAL.J.FOOD SCI.》 *
何可佳 等: "顶空毛细管气相色谱法测定富马酸喹硫平中残留有机溶剂", 《沈阳药科大学学报》 *
张治云 等: "气相色谱法测定富马酸替诺福韦二吡呋酯中三乙胺残留量", 《中国药师》 *
马振千 等: "气相色谱法测定富马酸卢帕他定中三乙胺的含量", 《广东化工》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111735884A (en) * 2020-08-04 2020-10-02 精晶药业股份有限公司 High performance gas chromatography detection method for triethylamine content in feed liquid
CN112379019A (en) * 2020-11-06 2021-02-19 郑州原理生物科技有限公司 Method for detecting residual solvent diethylamine in lidocaine hydrochloride
CN112782311A (en) * 2020-12-30 2021-05-11 南京百泽医药科技有限公司 HPLC (high performance liquid chromatography) determination method of L-isopropyl alanine in tenofovir disoproxil fumarate
WO2022151842A1 (en) * 2021-01-14 2022-07-21 浙江海正药业股份有限公司 Gas-phase chromatography detection method for dicyclohexylamine in favipiravir
CN112903866A (en) * 2021-02-02 2021-06-04 郑州泰丰制药有限公司 Method for determining triethylamine content in propane fumarate tenofovir

Similar Documents

Publication Publication Date Title
CN111323519A (en) Method for detecting triethylamine in propane fumarate tenofovir disoproxil through gas chromatography
CN112345651B (en) Method for determining content of halogenated acid in chloral hydrate or preparation thereof
CN104655751B (en) A kind of detect the method for organic solvent residual in dapoxetine
CN112557571B (en) Quantitative detection method for acryloyl chloride in preparation process of ibrutinib bulk drug
CN110715990A (en) Method for simultaneously detecting ACC007, lamivudine and tenofovir in plasma
Girault et al. Quantitative measurement of clenbuterol at the femtomole level in plasma and urine by combined gas chromatography/negative ion chemical ionization mass spectrometry
CN112630365A (en) Method for determining content of dimyristoyl phosphatidylcholine by high performance liquid chromatography
CN112710751A (en) Method for measuring tween 80 content in Xingnaojing injection
CN112710758A (en) Method for detecting residual solvent in tapentadol hydrochloride raw material medicine
CN114839287B (en) Method for detecting sodium myristate in miboplatin
CN112710762B (en) Method for measuring residual quantity of dimethyl sulfate
CN112213418B (en) Method for detecting related substances in sofosbuvir
CN113092607A (en) Detection method for residual solvent in loratinib raw material medicine
CN111505182A (en) Method for measuring dimethyl sulfate in medicine by derivatization gas chromatography-mass spectrometry
CN111175413B (en) Method for detecting content of 4-chlorobutanol acetate in sulfobutyl-beta-cyclodextrin sodium raw material or preparation thereof
CN116879428B (en) High performance liquid analysis method for residual content of phosphorylcholine in L-alpha-phosphorylcholine
CN113030321B (en) Fingerprint construction method and application of evodia rutaecarpa and asarum preparation
CN113777204B (en) Detection method of p-hydroxyacetophenone related substances
CN118032987A (en) Method for detecting isopentane and acetaldehyde residues in simvastatin
CN111175391A (en) Method for measuring residual amount of methanol in recombinant hand-foot-and-mouth disease vaccine stock solution and application of method in preparation of recombinant hand-foot-and-mouth disease vaccine
CN117388411A (en) Method for detecting trimethylsilanol in 2,3,4, 6-tetra-O-trimethylsilyl-D-glucolactone
CN117538455A (en) Method for detecting triethylamine solvent in thymalfasin
CN115184507A (en) Method for detecting N, N-diisopropyl carbodiimide and piperidine in polypeptide
CN113984927A (en) Gas chromatography analysis method for triethyl methanetricarboxylate related substances
CN113376294A (en) Analysis method of ethyl cyanoacetate in tofacitinib citrate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200623

RJ01 Rejection of invention patent application after publication